BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2336077)

  • 1. Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma.
    Trent JM; Meyskens FL; Salmon SE; Ryschon K; Leong SP; Davis JR; McGee DL
    N Engl J Med; 1990 May; 322(21):1508-11. PubMed ID: 2336077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistent karyotypic abnormalities in human malignant melanomas.
    Kacker RK; Giovanella BC; Pathak S
    Anticancer Res; 1990; 10(4):859-71. PubMed ID: 2382982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
    Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
    Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome alterations in human malignant melanoma.
    Trent JM; Leong SP; Meyskens FL
    Carcinog Compr Surv; 1989; 11():165-86. PubMed ID: 2646015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterogeneity of chromosomal abnormalities in cultured melanoma cells of human skin].
    Koliubaeva SN; Danilova AB; Baldueva IA; Krasnova OR; Viktorova NA; Kissel' AV; Timova AA
    Vopr Onkol; 2014; 60(5):596-601. PubMed ID: 25816664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.
    Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A
    Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic studies of human malignant melanoma cell lines.
    Yin M; Yoshida MA; Tonomura A; Kasuga T
    Bull Tokyo Med Dent Univ; 1992 Jun; 39(2):43-54. PubMed ID: 1505069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
    Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
    Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonrandom chromosome changes in malignant melanoma.
    Becher R; Gibas Z; Karakousis C; Sandberg AA
    Cancer Res; 1983 Oct; 43(10):5010-6. PubMed ID: 6883347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
    Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-random primary and secondary chromosomal abnormalities in human gastric cancers.
    Yadav M; Hopwood VL; Multani AS; Mansfield PF; Takahashi Y; McIntyre BW; Udagawa T; Pathak S
    Anticancer Res; 1996; 16(4A):1787-95. PubMed ID: 8712702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of structural rearrangements of chromosome 11 in human primary malignant melanoma.
    Nedoszytko B; Mrózek K; Limon J
    Cancer Genet Cytogenet; 1992 Feb; 58(2):196-7. PubMed ID: 1551088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics of melanocytic tumors.
    Parmiter AH; Nowell PC
    J Invest Dermatol; 1993 Mar; 100(3):254S-258S. PubMed ID: 8440899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma.
    Cools D; Debiec-Rychter M; Parys-Van Ginderdeuren R; Hagemeijer-Hausman A; Van den Oord J; Spileers W
    Bull Soc Belge Ophtalmol; 2000; (278):67-70. PubMed ID: 11761564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
    Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
    Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
    Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
    Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of numerical aberrations of chromosomes X and 11 and poor prognosis in squamous cell carcinomas of the head and neck.
    Xie X; Clausen OP; Boysen M
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):511-5. PubMed ID: 16702567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.